(Q30327334)

18 June 2017

Diabetes--a common, growing, serious, costly, and potentially preventable public health problem. (English)

1 reference

ORCID Public Data File 2021

18 June 2017

0 references

1 reference

author name string

Narayan KM

1

1 reference

18 June 2017

Gregg EW

2

1 reference

18 June 2017

Fagot-Campagna A

3

1 reference

18 June 2017

Engelgau MM

4

1 reference

18 June 2017

Vinicor F

5

1 reference

18 June 2017

1 October 2000

1 reference

Diabetes Research and Clinical Practice

18 June 2017

1 reference

18 June 2017

50 Suppl 2

1 reference

18 June 2017

S77-84

1 reference

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

18 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

Prevalence of self-rated visual impairment among adults with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

Excess costs of medical care for patients with diabetes in a managed care population

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

Expenditure on health care incurred by diabetic subjects in a developing country--a study from southern India

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

Preventing non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insuli

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

Evaluation of a diabetic foot screening and protection programme

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

Screening to prevent renal failure in insulin dependent diabetic patients: an economic evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

Racial and ethnic differences in glycemic control of adults with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

Population-based assessment of the level of care among adults with diabetes in the U.S.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

Exploring and expanding the research agenda for diabetes in managed care. A report of a Centers for Disease Control and Prevention-Managed Care Workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900183-2

7 January 2021

10.1016/S0168-8227(00)00183-2

Identifiers

DOI

1 reference

release_tvdt6422nffbnh55f2tzd6orjy

18 June 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tvdt6422nffbnh55f2tzd6orjy

24 November 2022

mapped directly with Wikidata item

1 reference